$ZOM
Zomedica Corp.

2024 Q4 Form 10-Q Financial Statement

#000155837024014859 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3 2023 Q3
Revenue $6.997M $6.347M
YoY Change 10.24% 32.89%
Cost Of Revenue $1.937M $1.985M
YoY Change -2.42% 63.37%
Gross Profit $5.060M $4.362M
YoY Change 16.0% 22.49%
Gross Profit Margin 72.32% 68.73%
Selling, General & Admin $10.66M $9.443M
YoY Change 12.83% 4.67%
% of Gross Profit 210.57% 216.48%
Research & Development $1.845M $867.0K
YoY Change 112.8% -23.34%
% of Gross Profit 36.46% 19.88%
Depreciation & Amortization $417.0K $1.596M
YoY Change -73.87% 1364.22%
% of Gross Profit 8.24% 36.59%
Operating Expenses $12.50M $10.31M
YoY Change 21.24% 1.55%
Operating Profit -$7.440M -$5.948M
YoY Change 25.08% -9.77%
Interest Expense $961.0K $64.00K
YoY Change 1401.56% -93.23%
% of Operating Profit
Other Income/Expense, Net -$111.0K $2.195M
YoY Change -105.06% -44000.0%
Pretax Income -$6.724M -$2.411M
YoY Change 178.89% -57.34%
Income Tax -$27.00K -$1.920M
% Of Pretax Income
Net Earnings -$6.697M -$491.0K
YoY Change 1263.95% -90.17%
Net Earnings / Revenue -95.71% -7.74%
Basic Earnings Per Share -$0.01 $0.00
Diluted Earnings Per Share -$0.01 $0.00
COMMON SHARES
Basic Shares Outstanding 979.9M 979.9M 979.9M
Diluted Shares Outstanding 979.9M 979.9M

Balance Sheet

Concept 2024 Q4 2024 Q3 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $76.88M $106.2M
YoY Change -27.62% -10.97%
Cash & Equivalents $9.747M $21.78M
Short-Term Investments $67.13M $84.42M
Other Short-Term Assets $2.579M $3.018M
YoY Change -14.55% -16.42%
Inventory $5.429M $3.737M
Prepaid Expenses
Receivables $1.759M $1.348M
Other Receivables $628.0K $1.084M
Total Short-Term Assets $87.27M $115.4M
YoY Change -24.37% -9.21%
LONG-TERM ASSETS
Property, Plant & Equipment $25.54M $8.259M
YoY Change 209.24% 22.77%
Goodwill $45.56M $73.77M
YoY Change -38.25% 14.86%
Intangibles $51.62M $56.93M
YoY Change -9.33% 33.08%
Long-Term Investments $966.0K $11.79M
YoY Change -91.8% -69.93%
Other Assets $1.143M $852.0K
YoY Change 34.15% 221.51%
Total Long-Term Assets $126.8M $159.7M
YoY Change -20.55% 2.88%
TOTAL ASSETS
Total Short-Term Assets $87.27M $115.4M
Total Long-Term Assets $126.8M $159.7M
Total Assets $214.1M $275.1M
YoY Change -22.15% -2.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.376M $5.598M
YoY Change -57.56% -10.35%
Accrued Expenses $4.667M $114.0K
YoY Change 3993.86% 178.05%
Deferred Revenue $293.0K $257.0K
YoY Change 14.01% 25.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $679.0K
YoY Change 17.47%
Total Short-Term Liabilities $8.064M $6.740M
YoY Change 19.64% -5.42%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $1.073M
YoY Change -100.0% 1.42%
Other Long-Term Liabilities $808.0K $1.433M
YoY Change -43.61% -50.1%
Total Long-Term Liabilities $808.0K $1.433M
YoY Change -43.61% -50.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.064M $6.740M
Total Long-Term Liabilities $808.0K $1.433M
Total Liabilities $11.27M $14.17M
YoY Change -20.45% 4.81%
SHAREHOLDERS EQUITY
Retained Earnings -$210.7M -$148.5M
YoY Change 41.87% 11.17%
Common Stock $413.3M $409.8M
YoY Change 0.85% 1.64%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $202.8M $260.9M
YoY Change
Total Liabilities & Shareholders Equity $214.1M $275.1M
YoY Change -22.15% -2.57%

Cashflow Statement

Concept 2024 Q4 2024 Q3 2023 Q3
OPERATING ACTIVITIES
Net Income -$6.697M -$491.0K
YoY Change 1263.95% -90.17%
Depreciation, Depletion And Amortization $417.0K $1.596M
YoY Change -73.87% 1364.22%
Cash From Operating Activities -$4.796M -$3.027M
YoY Change 58.44% 9.28%
INVESTING ACTIVITIES
Capital Expenditures $1.087M $9.215M
YoY Change -88.2% -598.38%
Acquisitions
YoY Change
Other Investing Activities $7.628M $6.092M
YoY Change 25.21% -104.45%
Cash From Investing Activities $6.541M -$3.123M
YoY Change -309.45% -97.75%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.00K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -4.796M -3.027M
Cash From Investing Activities 6.541M -3.123M
Cash From Financing Activities -70.00K 0.000
Net Change In Cash 1.675M -6.150M
YoY Change -127.24% -95.66%
FREE CASH FLOW
Cash From Operating Activities -$4.796M -$3.027M
Capital Expenditures $1.087M $9.215M
Free Cash Flow -$5.883M -$12.24M
YoY Change -51.94% 1229.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Entity Central Index Key
EntityCentralIndexKey
0001684144
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
979949668
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
979949668
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38298
dei Entity Registrant Name
EntityRegistrantName
Zomedica Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Z4
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Phoenix Drive
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 125
dei Entity Address City Or Town
EntityAddressCityOrTown
Ann Arbor
dei Entity Address State Or Province
EntityAddressStateOrProvince
MI
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
48108
dei City Area Code
CityAreaCode
734
dei Local Phone Number
LocalPhoneNumber
369-2555
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Shares
dei Trading Symbol
TradingSymbol
ZOM
dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
979949668
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
9747000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12952000
CY2024Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
67128000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Current
DebtSecuritiesAvailableForSaleExcludingAccruedInterestCurrent
77545000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1759000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1197000
CY2024Q3 us-gaap Inventory Net
InventoryNet
5429000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5123000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2579000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2064000
CY2024Q3 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
628000
CY2023Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1001000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
87270000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
99882000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
196000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Noncurrent
PrepaidExpenseAndOtherAssetsNoncurrent
250000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25540000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22828000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1828000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2466000
CY2024Q3 us-gaap Goodwill
Goodwill
45556000
CY2023Q4 us-gaap Goodwill
Goodwill
61580000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51616000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55364000
CY2024Q3 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Noncurrent
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent
966000
CY2023Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest Noncurrent
DebtSecuritiesAvailableForSaleExcludingAccruedInterestNoncurrent
10005000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1143000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
822000
CY2024Q3 us-gaap Assets
Assets
214115000
CY2023Q4 us-gaap Assets
Assets
253197000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2376000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2068000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
96000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
65000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
632000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
916000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
293000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
276000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4667000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5707000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8064000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9032000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1445000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1814000
CY2024Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
694000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1138000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
260000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
252000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
808000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
944000
CY2024Q3 us-gaap Liabilities
Liabilities
11271000
CY2023Q4 us-gaap Liabilities
Liabilities
13180000
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
979949668
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
979949668
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
380973000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
380973000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32292000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29929000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-210721000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-170933000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
300000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
48000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
202844000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
240017000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
214115000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
253197000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6997000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6347000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19390000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17849000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1937000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1985000
us-gaap Cost Of Revenue
CostOfRevenue
5851000
us-gaap Cost Of Revenue
CostOfRevenue
5604000
CY2024Q3 us-gaap Gross Profit
GrossProfit
5060000
CY2023Q3 us-gaap Gross Profit
GrossProfit
4362000
us-gaap Gross Profit
GrossProfit
13539000
us-gaap Gross Profit
GrossProfit
12245000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6765000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6115000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23366000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19977000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1845000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
867000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5122000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2645000
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3890000
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3328000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11920000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9826000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16024000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7440000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5948000
us-gaap Operating Income Loss
OperatingIncomeLoss
-42893000
us-gaap Operating Income Loss
OperatingIncomeLoss
-20203000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
977000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1437000
us-gaap Investment Income Net
InvestmentIncomeNet
3108000
us-gaap Investment Income Net
InvestmentIncomeNet
4309000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
64000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
175000
CY2024Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-134000
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
14000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-173000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
15000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-111000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2195000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2195000
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-16000
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-45000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-191000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-54000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6724000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2411000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-40124000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13913000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-27000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1920000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-336000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1790000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-491000
us-gaap Net Income Loss
NetIncomeLoss
-39788000
us-gaap Net Income Loss
NetIncomeLoss
-12123000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
225000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
244000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
223000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
520000
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
139000
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-19000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
29000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-62000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6333000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-266000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39536000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11665000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
979949668
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
208717000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
473000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
13000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
364000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
202844000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
240017000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2433000
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
70000
us-gaap Net Income Loss
NetIncomeLoss
-39788000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
252000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
202844000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
259482000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1668000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-491000
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
225000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
260884000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
267391000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
5158000
us-gaap Net Income Loss
NetIncomeLoss
-12123000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
458000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
260884000
us-gaap Net Income Loss
NetIncomeLoss
-39788000
us-gaap Net Income Loss
NetIncomeLoss
-12123000
us-gaap Depreciation
Depreciation
1102000
us-gaap Depreciation
Depreciation
538000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4834000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3890000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
16024000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-173000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
15000
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
2174000
us-gaap Share Based Compensation
ShareBasedCompensation
2433000
us-gaap Share Based Compensation
ShareBasedCompensation
5158000
zom Lease Expense Benefit Non Cash
LeaseExpenseBenefitNonCash
-15000
zom Lease Expense Benefit Non Cash
LeaseExpenseBenefitNonCash
-2000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1608000
us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
1716000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-116000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-444000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1960000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
660000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1350000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
460000
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-616000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
562000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
737000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-570000
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-193000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
308000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-547000
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
31000
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-73000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1048000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-524000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
25000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
137000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-136000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-271000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19105000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-10960000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-21091000
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-33240000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
437000
us-gaap Payments For Proceeds From Loans Receivable
PaymentsForProceedsFromLoansReceivable
1750000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4637000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9304000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
79000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
4120000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
12660000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15938000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5406000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
70000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-3237000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5554000
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
32000
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-62000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12952000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
27399000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9747000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21783000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
223000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
520000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
94000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
24000
zom Transfer Of Property And Equipment Into Intangibles
TransferOfPropertyAndEquipmentIntoIntangibles
1007000
zom Transfer Of Property And Equipment Into Intangibles
TransferOfPropertyAndEquipmentIntoIntangibles
2839000
zom Transfer Of Inventory Into Property And Equipment
TransferOfInventoryIntoPropertyAndEquipment
354000
zom Transfer Of Inventory Into Property And Equipment
TransferOfInventoryIntoPropertyAndEquipment
582000
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
1755000
us-gaap Proceeds From Interest And Dividends Received
ProceedsFromInterestAndDividendsReceived
2550000
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;font-style:italic;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Estimates and Assumptions</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">In preparing these condensed consolidated financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, and expenses.  These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate.  These estimates and assumptions are subject to an inherent degree of uncertainty.  We are not presently aware of any events or circumstances that would require us to update such estimates and assumptions or revise the carrying value of our assets or liabilities.  Our estimates may change, however, as new events occur, and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.</p>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;"><i style="font-style:italic;">Comparative Figures</i></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">To better align with the way we track our business, we’ve combined construction in progress into property and equipment, net, for the nine months ended September 30, 2024.  The consolidated balance sheets for the year ended December 31, 2023 have been adjusted to conform to the current year presentation of property and equipment, net.  The change in presentation had no effect on the reported results in our balance sheets and does not affect previously reported cash flows from investing activities in the consolidated statements of cash flows.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt;"><span style="font-size:9pt;visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:9pt;text-align:justify;margin:0pt;">To further enhance the transparency of our financial reporting, we have reclassified “Accounts payable” as its own line item, separating it from “Accounts payable and accrued liabilities.” Furthermore, we combined the accrued liabilities portion of “Accounts payable and accrued liabilities” with amounts previously included in “Other current liabilities” into a new line item, “Accrued expenses and other current liabilities”, to provide a comprehensive view of these obligations as of September 30, 2024. This presentation is supported by Note 10, “Accrued Expenses and Other Current Liabilities”, in the Notes to the Condensed Consolidated Financial Statements. The consolidated balance sheets for the year ended December 31, 2023, have been adjusted to align with the current presentation. The change in presentation had no impact on the reported results in our balance sheets and does not affect previously reported cash flows from operating activities in the consolidated statements of cash flows. Refer to Note 10 for further details. </p>
CY2024Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1468000
CY2023Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
1308000
zom Accounts Receivables Payment Term
AccountsReceivablesPaymentTerm
P30D
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
165000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
103000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6997000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6347000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19390000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17849000
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
72783000
CY2024Q3 zom Investment Securities Accumulated Accretion Or Amortization
InvestmentSecuritiesAccumulatedAccretionOrAmortization
954000
CY2024Q3 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
98000
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
73835000
CY2023Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
95367000
CY2023Q4 zom Investment Securities Accumulated Accretion Or Amortization
InvestmentSecuritiesAccumulatedAccretionOrAmortization
1177000
CY2023Q4 us-gaap Debt Securities Available For Sale Accumulated Gross Unrealized Gain Loss Before Tax
DebtSecuritiesAvailableForSaleAccumulatedGrossUnrealizedGainLossBeforeTax
-124000
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
96420000
CY2024Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
500000
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
586000
CY2024Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
72783000
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
73835000
CY2024Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
4674000
CY2023Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
3827000
CY2024Q3 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
284000
CY2023Q4 us-gaap Inventory Finished Goods And Work In Process
InventoryFinishedGoodsAndWorkInProcess
397000
CY2024Q3 zom Inventory Purchase
InventoryPurchase
478000
CY2023Q4 zom Inventory Purchase
InventoryPurchase
948000
CY2024Q3 us-gaap Inventory Gross
InventoryGross
5436000
CY2023Q4 us-gaap Inventory Gross
InventoryGross
5172000
CY2024Q3 us-gaap Inventory Adjustments
InventoryAdjustments
7000
CY2023Q4 us-gaap Inventory Adjustments
InventoryAdjustments
49000
CY2024Q3 us-gaap Inventory Net
InventoryNet
5429000
CY2023Q4 us-gaap Inventory Net
InventoryNet
5123000
CY2024Q3 us-gaap Deposit Assets
DepositAssets
244000
CY2023Q4 us-gaap Deposit Assets
DepositAssets
919000
CY2024Q3 us-gaap Prepaid Advertising
PrepaidAdvertising
488000
CY2023Q4 us-gaap Prepaid Advertising
PrepaidAdvertising
259000
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
610000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
436000
CY2024Q3 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
1433000
CY2023Q4 us-gaap Other Assets Miscellaneous
OtherAssetsMiscellaneous
700000
CY2024Q3 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2775000
CY2023Q4 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
2314000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2834000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4131000
CY2024Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
949000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1069000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
642000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
145000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
242000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
362000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4667000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5707000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
28544000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
24873000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3004000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2045000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25540000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22828000
CY2024Q3 us-gaap Depreciation
Depreciation
417000
CY2023Q3 us-gaap Depreciation
Depreciation
198000
us-gaap Depreciation
Depreciation
1102000
us-gaap Depreciation
Depreciation
538000
CY2023Q4 us-gaap Goodwill
Goodwill
61580000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16024000
CY2024Q3 us-gaap Goodwill
Goodwill
45556000
CY2024Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
16024000
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
66597000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
65511000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14981000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10147000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
51616000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55364000
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
563000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1605000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6319000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
5854000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
5627000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
5577000
CY2024Q3 zom Finite Lived Intangible Assets Amortization Expense Year Four And Thereafter
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourAndThereafter
26071000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
51053000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1611000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1398000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4834000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3890000
CY2022Q2 zom Maximum Percentage Of Shares To Be Reserved Under Plan
MaximumPercentageOfSharesToBeReservedUnderPlan
0.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4325000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9275000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4325000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9275000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
93349943
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3338
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
4325000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.1450
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
9457500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.2102
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1355500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.4861
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
86861943
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3355
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
47347774
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.3520
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
84112443
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3602
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
9275000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.2327
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2507500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.3292
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
1002500
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.9126
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
89877443
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.3397
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
31648974
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
0.3476
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
473000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1668000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2433000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5158000
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2727000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y
CY2024Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
15302000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6997000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
6347000
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
1937000
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
1985000
CY2024Q3 us-gaap Gross Profit
GrossProfit
5060000
CY2023Q3 us-gaap Gross Profit
GrossProfit
4362000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
19390000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17849000
us-gaap Cost Of Revenue
CostOfRevenue
5851000
us-gaap Cost Of Revenue
CostOfRevenue
5604000
us-gaap Gross Profit
GrossProfit
13539000
us-gaap Gross Profit
GrossProfit
12245000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-6697000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-491000
us-gaap Net Income Loss
NetIncomeLoss
-39788000
us-gaap Net Income Loss
NetIncomeLoss
-12123000
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
979949668
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01

Files In Submission

Name View Source Status
0001558370-24-014859-index-headers.html Edgar Link pending
0001558370-24-014859-index.html Edgar Link pending
0001558370-24-014859.txt Edgar Link pending
0001558370-24-014859-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zom-20240930.xsd Edgar Link pending
zom-20240930x10q.htm Edgar Link pending
zom-20240930xex10d3.htm Edgar Link pending
zom-20240930xex10d4.htm Edgar Link pending
zom-20240930xex10d5.htm Edgar Link pending
zom-20240930xex31d1.htm Edgar Link pending
zom-20240930xex31d2.htm Edgar Link pending
zom-20240930xex32d1.htm Edgar Link pending
zom-20240930_cal.xml Edgar Link unprocessable
zom-20240930_def.xml Edgar Link unprocessable
zom-20240930_lab.xml Edgar Link unprocessable
zom-20240930_pre.xml Edgar Link unprocessable
zom-20240930x10q_htm.xml Edgar Link completed